Mirugen
PrivateLast Round
Seed
Aug 14, 2025
Total Funding Raised
$4.55M
Company Overview
Mirugen is a biotechnology company developing gene therapy to treat blindness by reprogramming cells to unlock innate cellular repair mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirugen Comparables
Compare Mirugen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 78% | |
| Life Biosciences | 77% | |
| SparingVision | 76% | |
Mirugen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 14, 2025 | ||||
| Grant | Dec 23, 2024 |
Key People
Founding team and executive leadership
Mirugen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| ANDHealth | Grant |
| Brandon Capital | Seed |
| Tin Alley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2025
$3M round led by Brandon Capital, genesispsf, and Tin Alley Ventures.
- Dec 23, 2024
$1.27M grant round led by CUREator.
Mirugen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mirugen's valuation, stock price, and market status.